The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Oct. 14, 2020
Applicant:

Sunshine Lake Pharma Co., Ltd., Guangdong, CN;

Inventors:

Binbin Guo, Dongguan, CN;

Juan Li, Dongguan, CN;

Ping Song, Dongguan, CN;

Jiajun Guo, Dongguan, CN;

Liuxiao Tu, Dongguan, CN;

Fayin Tian, Dongguan, CN;

Buwen Zhao, Dongguan, CN;

Jinsong You, Dongguan, CN;

Fangfang Huang, Dongguan, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/27 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/19 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/27 (2013.01); A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 9/19 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/44 (2013.01);
Abstract

A ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate injection preparation contains ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate, a suspension agent, a stabilizer, an osmotic pressure adjustment agent, a pH regulator and a solvent; and the preparation may be a ready-to-use liquid injection and may also be a lyophilized powder for injection. The preparation has noticeable slow-release effects after injection, so that the drug action time can be prolonged, the frequency of dose can be reduced, the compliance of patients can be enhanced, and bioavailability can be increased. A method for preparing the above-mentioned ((((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)carbamoyl)oxy)-methyl benzoate injection preparation is simple, economical and suitable for industrial production.


Find Patent Forward Citations

Loading…